Investigating the active chemical constituents and pharmacology of Nanocnide lobata in the treatment of burn and scald injuries
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0287147 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Yanlin Zou und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Three Gorges Medical College, 404120, Chongqing, China. Hauptthemen laut MEDLINE: Interleukin-10, Burns. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Municipal Education Commission Science and Technology Research Project, Chongqing Municipal Health and Family Planning Commission Traditional Chinese Medicine Science and Technology Project, Scientific research and seedling breeding project of Chongqing Medical Biotechnology Association.
Abstract (Originalsprache)
Objective
To identify the most effective fraction of Nanocnide lobata in the treatment of burn and scald injuries and determine its bioactive constituents.
Methods
Chemical identification methods were used to analyze solutions extracted from Nanocnide lobata using petroleum ether, ethyl acetate, n-butanol using a variety of color reactions. The chemical constituents of the extracts were identified by ultra-performance liquid chromatography (UPLC)–mass spectrometry (MS). A total of 60 female mice were randomly divided into the following 6 groups: the petroleum ether extract-treated group; the ethyl acetate extract-treated group; the n-butanol extract-treated group; the model group; the control group; and the positive drug group. The burn/scald model was established using Stevenson’s method. At 24 hours after modeling, 0.1 g of the corresponding ointment was evenly applied to the wound in each group. Mice in the model group did not undergo treatment, while those in the control group received 0.1 g of Vaseline. Wound characteristics, including color, secretions, hardness, and swelling, were observed and recorded. Photos were taken and the wound area calculated on the 1 st , 5 th , 8 th , 12 th , 15 th , 18 th and 21 st days. Hematoxylin-eosin (HE) staining was utilized to observe the wound tissue of mice on the 7 th , 14 th , and 21 st days. An enzyme-linked immunosorbent assay (ELISA) kit was used to measure the expression of tumor necrosis factor (TNF)-α, interleukin (IL)-10, vascular endothelial growth factor (VEGF) and transforming growth factor (TGF)- β 1.
Results
The chemical constituents of Nanocnide lobata mainly include volatile oils, coumarins, and lactones. UPLC–MS analysis revealed 39 main compounds in the Nanocnide lobata extract. Among them, ferulic acid, kaempferitrin, caffeic acid, and salicylic acid have been confirmed to exhibit anti-inflammatory and antioxidant activity related to the treatment of burns and scalds. HE staining revealed a gradual decrease in the number of inflammatory cells and healing of the wounds with increasing time after Nanocnide lobata extract administration. Compared with the model group, the petroleum ether extract-treated group showed significant differences in the levels of TNF-α (161.67±4.93, 106.33±3.21, 77.67±4.04 pg/mL) and IL-10 (291.77±4.93, 185.09±9.54, 141.33±1.53 pg/mL) on the 7 th , 14 th , and 21 st days; a significant difference in the content of TGF- β 1 (75.68±3.06 pg/mL) on the 21 st day; and a significant difference in the level of VEGF (266.67±4.73, 311.33±10.50 pg/mL) on the 7 th and 14 th days respectively.
Conclusion
Petroleum ether Nanocnide lobata extract and the volatile oil compounds of Nanocnide lobata might be effective drugs in the treatment of burn and scald injuries, as they exhibited a protective effect on burns and scalds by reducing the expression of TNF-α, IL-10 and TGF-β1 and increasing the expression of VEGF. In addition, these compounds may also exert pharmacological effects that promote wound tissue repair, accelerate wound healing, and reduce scar tissue proliferation, inflammation and pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Three Gorges Medical College, 404120, Chongqing, China.
- School of Pharmacy, Chongqing Medical and Pharmaceutical College, 401331, Chongqing, China.
- Chongqing Anti-tumor Natural Drug Engineering Technology Research Center, Three Gorges Medical College, 404120, Chongqing, China.
- College of Pharmaceutical Sciences, Southwest University, 400715, Chongqing, China.
ORCID-Profile: Jingxin Mao
Förderung
- Chongqing Municipal Education Commission Science and Technology Research Project
- Chongqing Municipal Health and Family Planning Commission Traditional Chinese Medicine Science and Technology Project
- Scientific research and seedling breeding project of Chongqing Medical Biotechnology Association
- 2022 scientific research project of Chongqing Medical and Pharmaceutical College
Zitieren
APA
Zou, Y., Yu, C., Huang, Q., Tan, X., Tan, X., Zhu, X., Yi, D., & Mao, J. (2023). Investigating the active chemical constituents and pharmacology of Nanocnide lobata in the treatment of burn and scald injuries. PLOS ONE. https://doi.org/10.1371/journal.pone.0287147
Vancouver
Zou Y, Yu C, Huang Q, Tan X, Tan X, Zhu X, et al. Investigating the active chemical constituents and pharmacology of Nanocnide lobata in the treatment of burn and scald injuries. PLOS ONE. 2023. doi:10.1371/journal.pone.0287147
BibTeX
@article{Zou2023,
author = {Zou, Yanlin and Yu, Cao and Huang, Qian and Tan, Xiaorong and Tan, Xiaoyan and Zhu, Xiaolong and Yi, Dongyang and Mao, Jingxin},
title = {Investigating the active chemical constituents and pharmacology of Nanocnide lobata in the treatment of burn and scald injuries},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0287147}
}
EUVIMED